Splenic rupture following administration of pegfilgrastim in a patient with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.

Kuendgen, A; Fenk, R; Bruns, I; Dommach, M; Schutte, A; Engers, R; Hünerlitürkoglu, A; Haas, R; Kobbe, G

Kuendgen, A; Fenk, R; Bruns, I; Dommach, M; Schutte, A; Engers, R; Hünerlitürkoglu, A; Haas, R; Kobbe, G.

Bone Marrow Transplant ; 38(1): 69-70, 2006 Jul.

Article in En | MEDLINE | ID: mdl-16715114

Subject(s)

Granulocyte Colony-Stimulating Factor/adverse effects; Multiple Myeloma/therapy; Peripheral Blood Stem Cell Transplantation; Splenic Rupture/complications; Splenic Rupture/drug therapy; Adult; Female; Filgrastim; Granulocyte Colony-Stimulating Factor/administration & dosage; Humans; Polyethylene Glycols; Recombinant Proteins; Risk Factors; Rupture, Spontaneous; Splenic Rupture/diagnosis; Transplantation, Autologous; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Splenic Rupture / Granulocyte Colony-Stimulating Factor / Peripheral Blood Stem Cell Transplantation / Multiple Myeloma Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2006 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links